CoChat

Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes

The DOI matches its Crossref record; 413 of the 418 references it cites were found in a registry or an index.

Abstract

In both type 1 and type 2 diabetes, the late diabetic complications in nerve, vascular endothelium, and kidney arise from chronic elevations of glucose and possibly other metabolites including free fatty acids (FFA). Recent evidence suggests that common stress-activated signaling pathways such as nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases underlie the development of these late diabetic complications. In addition, in type 2 diabetes, there is evidence that the activation of these same stress pathways by glucose and possibly FFA leads to both insulin resistance and impaired insulin secretion. Thus, we propose a unifying hypothesis whereby hyperglycemia and FFA-induced activation of the nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases stress pathways, along with the activation of the advanced glycosylation end-products/receptor for advanced glycosylation end-products, protein kinase C, and sorbitol stress pathways, plays a key role in causing late complications in type 1 and type 2 diabetes, along with insulin resistance and impaired insulin secretion in type 2 diabetes. Studies with antioxidants such as vitamin E, α-lipoic acid, and N-acetylcysteine suggest that new strategies may become available to treat these conditions.

Overview

Integrity signals

Registry

Crossref · 10.1210/er.2001-0039

Cites

413 of 413 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 413 references

Research works printed but not linked: 4

  1. Yuan, 2000, Salicylate inhibition of IKKβ (IκB kinase) reverses insulin resistance in Zucker (fa/fa) rats, Diabetes, 49, A292
  2. Hundal, 2001, Potential for a novel class of insulin sensitizing agents by inhibition of IKKβ activity, Diabetes, 50, A117
  3. Liang, 1991, Glucose at physiological levels induces glucokinase, glucose usage, and insulin secretion in cultures pancreatic islets, Diabetes, 40, 177A
  4. Grodsky, 1968, Factors influencing different rates of insulin release, Acta Diabetol Lat, 1, 140

Cited by

See all 2,232

Metadata

Authors
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M.
Affiliations
  • Medical Research Institute (J.L.E.), San Bruno, California 94066
  • University of California, San Francisco (US)
Venue
Endocrine Reviews
Published
2002-10-01
Volume
23
Issue
5
Pages
599-622
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2083990676
Cited by
2,232
References
418
Citations by year
2026: 49 · 2025: 57 · 2024: 67 · 2023: 65 · 2022: 77 · 2021: 83 · 2020: 83 · 2019: 98 · 2018: 95 · 2017: 104 · 2016: 105 · 2015: 143 · 2014: 138 · 2013: 135 · 2012: 146
FWCI
9.80
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
type 2 diabetes, type 1 diabetes, oxidative stress, nuclear factor-kappaB, p38 MAPK, c-Jun N-terminal kinase, advanced glycation end products, protein kinase C, polyol pathway, hyperglycemia, free fatty acids, insulin resistance, impaired insulin secretion, diabetes complications, antioxidants, vitamin E, alpha-lipoic acid, N-acetylcysteine
MeSH terms
Animals, Antioxidants, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Insulin Resistance, Islets of Langerhans, Lymphokines, Signal Transduction, Endothelial Growth Factors, NF-kappa B, Reactive Oxygen Species, Oxidative Stress, Mitogen-Activated Protein Kinases, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.